Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Get AMPed: Understanding RA Through the Accelerating Medicines Partnership

Jason Liebowitz, MD, FACR  |  December 7, 2023

Imaging

Andrew Filer, PhD

The final speaker in the session, Andrew Filer, FRCP, PhD, professor of translational and experimental rheumatology, University of Birmingham, U.K., spoke on the subject of imaging of RA synovium in order to better understand the cellular architecture of synovitis. Referring back to the concept of CTAPs, Dr. Filer pointed out that, using low dimension stains from synovial tissue, two things can be shown: 1) what is happening in the CTAPs in terms of cell types can be replicated with histology and 2) consistent findings can be seen in the same joint when comparing disaggregated synovial tissue and four to six tissue samples that have been biopsied and stained.

The main thrust of the work from Dr. Filer and colleagues has to do with the concept of obtaining synovial tissue biopsies and projecting cell clusters onto the tissue space. In doing so, it has been possible to demonstrate that there is diversity within the RA synovium (and that this diversity has spatial and regional correlates) and that T and B cell CTAPs and the myeloid cell CTAPs differ in their macrophage/lymphocyte niches. These findings may have important implications for treatment targets for patients who fall into different CTAP groups.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In Sum

The session was notably innovative and represents the cutting edge when it comes to better understanding and, ultimately, treating conditions like RA using advanced technologies for investigation. With such a granular understanding disease, rheumatologists may one day be able to tell patients how their condition can be impacted even at most microscopic level.


Jason Liebowitz, MDJason Liebowitz, MD, is an assistant professor of medicine in the Division of Rheumatology at Columbia University Vagelos College of Physicians and Surgeons, New York.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Zhang F, Jonsson AH, Nathan A, et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature. 2023;623(7987):616–624.
  2. Dunlap G, Wagner A, Meednu N, et al; Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network, et al. Clonal associations of lymphocyte subsets and functional states revealed by single cell antigen receptor profiling of T and B cells in rheumatoid arthritis synovium. bioRxiv [Preprint]. 2023 Mar 21:2023.03.18.533282.
  3. Kozlowska J, Humphryes-Kirilov N, Pavlovets A, et al. New genetic insights in rheumatoid arthritis using taxonomy3, a novel method for analysing human genetic data. medRxiv [Preprint]. 2023 Feb 21:2023.02.21.23286176.
  4. Weinand K, Sakaue S, Nathan A, et al; Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network; et al. The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis. bioRxiv [Preprint]. 2023 Apr 8:2023.04.07.536026.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsRheumatoid Arthritis Tagged with:Accelerating Medicines PartnershipACR Convergence 2023RA Resource Center

Related Articles

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    New Tech Provides Insights Into the Pathogenesis of Psoriatic Arthritis

    May 5, 2022

    The etiology of psoriatic arthritis (PsA) is poorly understood but current evidence supports an interaction between genetic and environmental factors that coalesce to promote local tissue inflammation.1-3 The pivotal cytokines that underlie the local inflammatory response in a wide range of tissues are interleukin (IL) 23, IL-17 and tumor necrosis factor (TNF).4 The central contribution…

    Th 17 Cells and Arthritis

    July 1, 2008

    The true story of how IL-17 became a focus for RA research

    Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease

    January 1, 2010

    A perspective on B cell–targeted therapies in autoimmune disease

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences